Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
5,279,998
-
Share change
-
+1,325,843
-
Total reported value
-
$81,047,000
-
Price per share
-
$15.35
-
Number of holders
-
9
-
Value change
-
+$20,684,812
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q3 2017
As of 30 Sep 2017,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,279,998 shares.
The largest 9 holders included
Vivo Capital, LLC, NEA Management Company, LLC, Novo Holdings A/S, ORBIMED ADVISORS LLC, Foresite Capital Management III, LLC, Tekla Capital Management LLC, PERCEPTIVE ADVISORS LLC, Polar Capital LLP, and Tower Research Capital LLC (TRC).
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.